Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Anthem Inc. CORP UNIT 050118
ANTX | US
3.26
USD0.28
9.40%
ANTX | US
Loading StockChartView...
About Anthem Inc. CORP UNIT 050118
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
15/04/2026
Close
3.26
Open
2.91
High
3.27
Low
2.87
AN2 Therapeutics Inc. a clinical-stage biopharmaceutical company focuses on developing treatments for rare chronic and serious infectious diseases. It is developing epetraborole which is in a pivotal Phase 2/3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park California.
View LessANTX | US
Risk
83.6
Sharpe
1.16
Luna's Score
55/100
Recommendation
Hold
Luna says (ANTX | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
77.6%1 month
83.6%3 months
236.3%6 months
175.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.32
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-2.11
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
97.29M
MarketCap(USD)
97.29M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-69.48
Short ratio
0.75
Short perc.
0.98
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.80
Range1M
2.32
Range3M
5.91
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
2.54
Price X volume
3.42M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.11 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.32 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 236.35 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 97.29M | 3.66B | Emerging |
